iShares Core MSCI EAFE

HSBC Facilitates Tencent's Issuance of $2.45 Billion and 15 Billion RMB Notes

HSBC Raises 2026-2030 Global AI Industry Revenue Forecast to $2.5 Trillion

HSBC Private Bank Launches HSBC Access in HK, Opening Tech Startup Investments to UHNW Clients

HSBC Plans to Launch HKD Stablecoin in Second Half to Enhance Cross-border Transfers

AstraZeneca Obesity Oral Drug Shows 10.5% Weight Loss in Trials

After Standard Chartered CEO AI controversy, HSBC CEO Eric Hsieh: Humans remain core of banking even with AI, hiring may increase

AstraZeneca May Suspend New Drug Supply to Europe

Bernstein Reaffirms Outperform Rating on AstraZeneca, Highlights Non-Oncology Growth Potential for 2035 Sales

Bank of America raises HSBC target price to 168.8 HKD, reiterates Buy rating

SJTU Team Publishes DURABLE Study: Durvalumab Plus Anlotinib Improves Survival in Small Cell Lung Cancer

Roche rapidly develops a PCR test for Ebola within six days

HSBC faces allegations of misappropriating funds from Lebanon in French investigation

HSBC Obtains Stablecoin License, Plans to Launch HKD Stablecoin in Second Half of Year

AstraZeneca Reports Positive SERENA-6 Trial Results, Yet Stock Falls

HSBC Launches HDSU Blockchain Settlement Tool with Significant Cost and Efficiency Gains in Pilot

Genentech to Present Clinical Data for Obesity Drugs Enicepatide and Petrelintide at ADA 2026, Roche Shares Rise 1.82%

AstraZeneca Reports EMERALD-3 Trial Results: Combination Therapy Reduces Death Risk in Liver Cancer Patients by 30%

HSBC Executives Step Up to Revitalize HK Investment Banking Business, Poach from JPMorgan to Expand Footprint

CCSC Tech

Youlife

Core AI

Regentis Biomaterials

Epsium Enterprise

Autozi Internet Tech Global

Leslies

Mega Matrix

eLong Power

Smart Logistics Global

AstraZeneca is advancing its oral GLP-1 receptor agonist, elecoglipron, into Phase 3 trials following positive Phase 2b results. The drug demonstrated significant weight loss (up to 11.8%) in obesity patients and improved HbA1c control (90% below 7%) in Type 2 diabetes patients. Safety profiles were manageable with mild gastrointestinal side effects. AstraZeneca shares rose 0.73% to $182.88.

benzinga_article

AstraZeneca

AstraZeneca PLC

Eli Lilly

Shutterstock

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials

00005

HSBA

HSBC

HSBH

HSBC Private Bank launched 'HSBC Access', a new offering for ultra-high-net-worth individuals and family offices. This initiative provides access to institutional-grade private market investments, including direct deals and venture capital funds in technology and startups. It marks the first time these clients can invest via HSBC Innovation Banking since its 2023 establishment. The platform offers market intelligence and founder introductions, initially rolling out in Hong Kong before expanding globally to meet growing demand.

- HSBC Private Bank has launched «HSBC Access» to enhance UHNW individuals' access to private market investments and innovation.  
- This platform enables clients to invest in selected technology and start-up companies, previously available only to institutional investors, through HSBC's Banking divisions.  
- The initiative addresses growing demand for private investment opportunities and aims to broaden funding options for entrepreneurs, with plans for global expansion following its initial rollout in Hong Kong.

FiNews

HSBC HOLDINGS

HSBC Holdings Plc

HSBC Holdings plc ADRhedged

HSBC 5xShortSG241213

HSBC Private Bank Launches new offering for wealthy clients

HSBC is considering offering non-HKD stablecoins to enhance cross-border transfers and aims to launch a HKD stablecoin in H2. The token will integrate into HSBC's app for payments and tokenized asset investments.

CoinLive

HSBC Considers Non-HKD Stablecoins and Targets H2 Launch for HKD Stablecoin

Clearbridge Investments LLC increased its HSBC Holdings stake by 77.0% in Q4, holding 1.44 million shares valued at $113.6 million. Other institutions like Sivia Capital and Invesco also boosted holdings. Meanwhile, HSBC declared a $0.50 quarterly dividend with an ex-date of May 15, despite negative sentiment from reports on Hong Kong bank scrutiny and whistleblower allegations.

- Clearbridge Investments LLC increased its holdings in HSBC Holdings plc by 77.0% in Q4, owning 1,443,716 shares valued at $113.58 million after purchasing an additional 627,857 shares.  
- Other hedge funds, including Sivia Capital and Invesco Ltd., also boosted their stakes, reflecting confidence in HSBC despite concerns about Hong Kong banking regulations.  
- HSBC has a market cap of $312.22 billion and recently reported quarterly earnings of $0.44 EPS with revenue of $19.13 billion, while facing mixed analyst ratings from various research firms.

Market Beat

Invesco

Standard Chartered PLC

STANCHART

Citigroup

ROYAL BANK OF CANADA

Goldman Sachs

AIA-R

AIA Group

CITIGROUP INC 6.250 NON CUM SER II PFD WI

GS Hldg R

Clearbridge Investments LLC Boosts Holdings in HSBC Holdings plc $HSBC

00813

02388

Shimao Group reportedly defaulted on a HKD4.5 billion loan, prompting multiple banks to plan the takeover of two Sheraton hotels in Tung Chung. Lenders are discussing appointing receivers to accelerate asset disposal and fund recovery. The original lenders included HSBC, Bank of China Hong Kong, and Bank of East Asia.

- SHIMAO GROUP defaulted on a HKD 4.5 billion loan, prompting several banks to take over the Sheraton Tung Chung Hotel and Four Points by Sheraton Tung Chung near Hong Kong International Airport.  
- The banks are in advanced discussions to appoint receivers to manage the assets for quicker disposals and fund recovery.  
- Original lenders include HSBC, BOC Hong Kong, and Bank of East Asia, among others.

AASTOCKS News

SHIMAO GROUP

BOC HONG KONG

BANK OF E ASIA

Bank of China

BANK OF CHINA

Bank Of China

SHIMAO GROUP  Reportedly Defaults on HKD4.5B Loan; Two Sheraton Hotels in Tung Chung May Be Taken Over

Dubai Islamic Bank (DIB) has mandated a USD-denominated perpetual non-call six-year benchmark AT1 sukuk. A consortium of banks, including Arqaam Capital, HSBC, and FAB, serves as joint lead managers. The virtual roadshow began on June 8, with listings expected on Euronext Dublin and Nasdaq Dubai under FCA/ICMA stabilization rules.

- Dubai Islamic Bank (DIB) has mandated a dollar-denominated perpetual non-call six-year benchmark AT1 sukuk, rated A3 by Moody’s and A by Fitch.  
- A virtual deal roadshow commenced on June 8, with several banks appointed as joint lead managers and bookrunners for the issuance.  
- The sukuk is expected to list on Euronext Dublin and Nasdaq Dubai, with applicable FCA/ICMA stabilization rules.

Zawya

Moodys

Mizuho Financial

Mizuho Financial Group, Inc.

Nasdaq

ZAWYA: Dubai Islamic Bank mandates USD AT1 PNC 6-year sukuk

02888

STAN

HSBC CEO Georges Elhedery emphasized that human judgment remains vital despite AI integration, asserting that people are central to banking. While acknowledging AI's potential for productivity and personalized services, he insisted on the need for human accountability and suggested future hiring needs. This contrasts with recent industry trends of job cuts, such as Standard Chartered's controversial remarks, though Bloomberg reports HSBC may still cut up to 10% of its workforce.

- HSBC CEO Georges Elhedery emphasized the importance of human judgment and decision-making in banking, even with the rise of artificial intelligence (AI).  
- While he acknowledged that AI could enhance productivity and client services, he suggested that it might lead to future job creation at HSBC, despite the potential for job cuts as seen in other banks.  
- Elhedery stated that HSBC is committed to integrating AI in its operations, currently utilizing it for compliance checks, indicating a shift towards more capabilities in the banking sector.

Businesstimes News

‘Human judgment’ is vital even with AI’s introduction, HSBC CEO says

AstraZeneca to report late-stage Datroway + Imfinzi lung cancer trial results later this year; continues Datroway studies in earlier-stage breast cancer and highlights patient-selection focus. 1AstraZeneca (AZN) moved its primary listing to the New York Stock Exchange in February. Shares now trade on the NYSE; this was the largest market-capitalization listing transfer in NYSE history. 2

TradingView

Key facts: AstraZeneca to report Datroway+Imfinzi results; NYSE move

AstraZeneca celebrated its transfer to the NYSE, marking the largest transfer by market capitalization in the exchange's 234-year history. CEO Pascal Soriot and CFO Aradhana Sarin discussed financial goals for 2030. Meanwhile, Sunshine Silver Mining & Refining shares jumped 27% on its debut, and fintech RedotPay unveiled a new B2B product.

Unusual Whales

NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History

HSHD

French prosecutors have filed preliminary charges against HSBC Holdings' Swiss private banking arm, alleging it assisted former Lebanese central bank governor Riad Salameh in misappropriating funds. This step allows the case to be referred to an investigating judge for a deeper probe. HSBC stated it cannot comment on legal matters but will continue cooperating with authorities. The bank previously disclosed ongoing investigations into suspected money laundering and terminated relationships with over 1,000 Middle Eastern clients.

- French prosecutors have filed preliminary charges against HSBC's Swiss private banking arm for allegedly assisting former Lebanese central bank governor Riad Salameh in fund misappropriation.  
- This filing indicates sufficient evidence for an investigation, with a judge to determine if the case will proceed further.  
- HSBC is under investigation for suspected money laundering and has already terminated relationships with over 1,000 wealthy Middle Eastern clients due to this ongoing inquiry.

HSBC HK SDR 5to1

HSBC HOLDINGS Faces Prelim Charges by French Prosecutors over Lebanon Central Bank Scandal

iShares Core MSCI EAFE(IEFA.US)